C4BPB
C4b-binding protein beta chain
Also known as: C4BP, C4BPB_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P20851
- Gene
- C4BPB
- Ensembl
- ENSG00000123843
- Chromosome
- 1
- Canonical length
- 252 aa
- Protein class
- Human disease related genes, Plasma proteins, Predicted secreted proteins
- Subcellular location
- Golgi apparatus
- Secretome location
- Secreted to blood
- Quaternary structure
- Homoheptamer
OverviewNCBI Gene
This gene encodes a member of a superfamily of proteins composed predominantly of tandemly arrayed short consensus repeats of approximately 60 amino acids. A single, unique beta-chain encoded by this gene assembles with seven identical alpha-chains into the predominant isoform of C4b-binding protein, a multimeric protein that controls activation of the complement cascade through the classical pathway. C4b-binding protein has a regulatory role in the coagulation system also, mediated through the beta-chain binding of protein S, a vitamin K-dependent protein that serves as a cofactor of activated protein C. The genes encoding both alpha and beta chains are located adjacent to each other on human chromosome 1 in the regulator of complement activation gene cluster. Alternative splicing gives rise to multiple transcript variants. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
252 residues, UniProt reviewed canonical sequence.
>P20851|C4BPB
1 MFFWCACCLM VAWRVSASDA EHCPELPPVD NSIFVAKEVE GQILGTYVCI KGYHLVGKKT
61 LFCNASKEWD NTTTECRLGH CPDPVLVNGE FSSSGPVNVS DKITFMCNDH YILKGSNRSQ
121 CLEDHTWAPP FPICKSRDCD PPGNPVHGYF EGNNFTLGST ISYYCEDRYY LVGVQEQQCV
181 DGEWSSALPV CKLIQEAPKP ECEKALLAFQ ESKNLCEAME NFMQQLKESG MTMEELKYSL
241 ELKKAELKAK LLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against C4BPB can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.41
- Highest tissue expression
- 440 nTPM
Expression across tissuesHPA
Tissue
- liver: 440 nTPM
- ovary: 34 nTPM
- pancreas: 9.1 nTPM
- stomach: 8.2 nTPM
- placenta: 5.8 nTPM
- small intestine: 4.2 nTPM
Single-cell type
- hepatocytes: 686 nCPM
- cholangiocytes: 72 nCPM
- breast lactating cells: 56 nCPM
- gastric progenitor cells: 50 nCPM
- parietal cells: 41 nCPM
- ovarian stromal cells: 40 nCPM
Immune cell
- plasmacytoid DC: 1.1 nTPM
- naive CD4 T-cell: 0.7 nTPM
- naive CD8 T-cell: 0.2 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
Brain region
- white matter: 0.5 nTPM
- cerebral cortex: 0.4 nTPM
- pons: 0.4 nTPM
- amygdala: 0.3 nTPM
- basal ganglia: 0.3 nTPM
- hypothalamus: 0.3 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about C4BPB.
Disease | ImmuneIEDB
Conditions an epitope on C4BPB was assayed in.
- rheumatoid arthritis B cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.3
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.46
- DepMap mean gene effect
- -0.06
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- blood coagulation
- complement activation, classical pathway
- innate immune response
- negative regulation of complement activation, classical pathway
- positive regulation of protein catabolic process
- regulation of opsonization
- response to symbiotic bacterium
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads C4BPB as an antibody target. Whether an autoantibody or antibody against C4BPB could matter depends on whether native C4BPB is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
C4BPB is annotated as secreted, so native C4BPB circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label C4BPB as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...